Sun Pharmaceutical Industries Ltd. calendar
Nothing is on the exchange's calendar ahead for Sun Pharmaceutical Industries Ltd. today. In the last twelve months the exchange listed 8 board meetings or events for it, the latest on 31 July 2026: board meeting intimation.
Ahead
Nothing dated ahead on the exchange's calendar.
The last twelve months
| Date | Purpose | As told to the exchange | Where |
|---|---|---|---|
| 31 July 2026 | Board Meeting Intimation | SUN PHARMACEUTICAL INDUSTRIES LIMITED has informed the Exchange about Board Meeting to be held on 31-Jul-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2026 . | NSE |
| 31 July 2026 | Financial Results | To consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter ended 30 June 2026 | NSE |
| 22 May 2026 | Board Meeting Intimation | SUN PHARMACEUTICAL INDUSTRIES LIMITED has informed the Exchange about Board Meeting to be held on 22-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend. | NSE |
| 22 May 2026 | Financial Results/Dividend | To consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and year ended 31 March 2026 and recommendation of final dividend for FY 2025-26 | NSE |
| 31 January 2026 | Board Meeting Intimation | SUN PHARMACEUTICAL INDUSTRIES LIMITED has informed the Exchange about Board Meeting to be held on 31-Jan-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2025 and Dividend. | NSE |
| 31 January 2026 | Financial Results/Dividend | To consider and approve the financial results for the quarter and nine months ended 31 December 2025, and the interim dividend for FY 2025-26 | NSE |
| 5 November 2025 | Board Meeting Intimation | SUN PHARMACEUTICAL INDUSTRIES LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2025 . | NSE |
| 5 November 2025 | Financial Results | To consider and approve the Unaudited financial results for the quarter and half year ended 30 September 2025. | NSE |
Board meeting intimations and calendar entries as the company told the exchange; a results date appears here about a week before the meeting.
Annual reports
| Financial year | Filed | Size | Report |
|---|---|---|---|
| 2025 to 2026 | 6 July 2026 | 19.00 MB | |
| 2024 to 2025 | 4 July 2025 | ||
| 2023 to 2024 | |||
| 2022 to 2023 | 27 July 2023 | ||
| 2021 to 2022 | 5 August 2022 | ||
| 2020 to 2021 | |||
| 2019 to 2020 | |||
| 2018 to 2019 | |||
| 2017 to 2018 | 1 October 2018 | ||
| 2016 to 2017 | 29 September 2017 | ||
| 2015 to 2016 | 23 September 2016 | ||
| 2014 to 2015 | 6 October 2015 |
The annual reports the company filed with the exchange, as PDFs.
Source
The event calendar on nseindia.com and the board-meeting and annual-report lists for SUNPHARMA.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.